Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience

被引：0
|
作者：
Dukovski, Dushko [1 ]
Trajkova, Sanja [1 ]
Stojanovska, Simona [1 ]
Ridova, Nevenka [1 ]
Panovska-Stavridis, Irina [1 ]
机构：
[1] Clin Hematol, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
CML; imatinib; selective tyrosine kinase inhibitor (TKI); chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-104
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [41] Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients
    Li, Yuxin
    Zhang, Yilin
    Wang, Jin
    He, Aili
    Zhang, Wanggang
    Cao, Xingmei
    Chen, Yinxia
    Liu, Jie
    Zhang, Pengyu
    Wang, Jianli
    Zhao, Wanhong
    Yang, Yun
    Meng, Xin
    Chen, Sheping
    Zhang, Longjin
    Wang, Ting
    Wang, Xugeng
    Ma, Xiaorong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia
    Baran, Yusuf
    Saydam, Guray
    JOURNAL OF BLOOD MEDICINE, 2012, 3 : 139 - 150
  • [43] Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study
    Entasoltan, B.
    Bekadja, M. A.
    Touhami, H.
    Mehalhal, N.
    Zouaoui, Z.
    Mesli, N.
    Talbi, M.
    Bachiri, A.
    Michallet, M.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [44] Improved Outcome in Patients with Chronic Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Over the Past 25 Years: A Single-Center Experience
    Boehm, Alexandra
    Walcherberger, Barbara
    Sperr, Wolfgang R.
    Woehrer, Stefan
    Dieckmann, Karin
    Rosenmayr, Agathe
    Pernicka, Elisabeth
    Fischer, Gottfried
    Worel, Nina
    Mitterbauer, Gerlinde
    Schwarzinger, Ilse
    Mitterbauer, M.
    Haas, Oskar A.
    Lechner, Klaus
    Hinterberger, W.
    Valent, Peter
    Greinix, Hildegard T.
    Rabitsch, Werner
    Kalhs, Peter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : 133 - 140
  • [45] Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India
    Mukhopadhyay, A.
    Dasgupta, S.
    Mukhopadhyay, S.
    Bose, C. K.
    Sarkar, S.
    Gharami, F.
    Koner, S.
    Basak, J.
    Roy, U. K.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (02) : 82 - 88
  • [46] Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India
    A. Mukhopadhyay
    S. Dasgupta
    S. Mukhopadhyay
    C. K. Bose
    S. Sarkar
    F. Gharami
    S. Koner
    J. Basak
    U. K. Roy
    Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 82 - 88
  • [47] Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients
    Emilia Scalzulli
    Gioia Colafigli
    Roberto Latagliata
    Sara Pepe
    Daniela Diverio
    Francesca Stocchi
    Alessio Di Prima
    Fabio Efficace
    Maurizio Martelli
    Robin Foà
    Massimo Breccia
    Annals of Hematology, 2020, 99 : 2773 - 2777
  • [48] Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients
    Scalzulli, Emilia
    Colafigli, Gioia
    Latagliata, Roberto
    Pepe, Sara
    Diverio, Daniela
    Stocchi, Francesca
    Di Prima, Alessio
    Efficace, Fabio
    Martelli, Maurizio
    Foa, Robin
    Breccia, Massimo
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2773 - 2777
  • [49] Diagnosis and Treatment of Chronic Myeloid Leukemia in the Imatinib Mesylate Era: Report of the Experience at "La Raza" Medical Center in Mexico
    Ayala, Manuel
    Avila, Elsa
    Dominguez, Jacqueline
    Aquino, Xochitl
    Vela, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (02) : 57 - 62
  • [50] Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic myeloid leukemia in the chronic phase: A real-world single-center retrospective study, with a focus on premature drug discontinuation
    Sun, Mingshan
    Li, Shijie
    Liu, Zhenyi
    Ma, Sai
    Liu, Xiaohan
    Meng, Qing
    Zheng, Yueyue
    Chen, Chunyan
    LEUKEMIA RESEARCH, 2024, 142
12345